オプションチェーンは、Japan Airlines Coの株式オプションの主要データを様々な行使価格と満期日で表示します。トレーダーはこの情報を使用して、潜在的な取引を分析し、Japan Airlines Coの市場センチメントを評価します。.

Japan Airlines Co (OTC:JPNRF) 株価情報, オプションチェーン

Japan Airlines Co Ltd is an international air transport services company. It offers scheduled and nonscheduled air transport services and aerial work services. The company operates large aircraft, medium-size aircraft, small aircraft, and regional jets. JAL's route network comprises over 100 domestic routes and over 50 international routes. The airline flies to over 50 countries and regions and connects over 300 airports.

Boeing Stock Wiped Out 47% Of Investor Wealth Over The Last 5 Years Amid Multiple Issues — Now, This Expert Suggests A Breakup Could Benefit The Airplane Maker

News

European Aeronautic Defence And Space Unsponsored

EADSY

JAPSY

JPNRF

水曜日の発表によると、日本航空（Japan Airlines）（OTC:JAPSY）（OTC:JPNRF）がボーイング（Boeing Co.）（NYSE:BA）から、2023年3月に発注した2型21機に加え、17機のボーイング737-8型機を追加導入することを決定した。国内線の就航路線で使われている737-800型機の更新機材となる。

日本航空、ボーイング737-8機を追加導入決定

JAPAN AIRLINES CO JAL ORD by Japan Airlines Co Ltd JAL

Japan Airlines Co Ltd

Stifel analyst Stephen Willey maintains Vor Biopharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VOR#NASDAQ">VOR</a>) with a Buy and lowers the price target from $12 to $5.

Price Target

Analyst Ratings

Stifel Maintains Buy on Vor Biopharma, Lowers Price Target to $5

Stephens &amp; Co. analyst Jim Salera maintains Darden Restaurants (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DRI#NYSE">DRI</a>) with a Equal-Weight and raises the price target from $175 to $178.

Stephens & Co. Maintains Equal-Weight on Darden Restaurants, Raises Price Target to $178

Stifel analyst J. Bruce Chan maintains FedEx (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FDX#NYSE">FDX</a>) with a Buy and lowers the price target from $364 to $354.

Stifel Maintains Buy on FedEx, Lowers Price Target to $354

Telsey Advisory Group analyst Dana Telsey maintains Torrid Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CURV#NYSE">CURV</a>) with a Market Perform and raises the price target from $5 to $6.

CURV

Telsey Advisory Group Maintains Market Perform on Torrid Holdings, Raises Price Target to $6

Stifel analyst Chris O'Cull maintains Darden Restaurants (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DRI#NYSE">DRI</a>) with a Buy and raises the price target from $205 to $215.

Stifel Maintains Buy on Darden Restaurants, Raises Price Target to $215

Telsey Advisory Group analyst Cristina Fernandez maintains Academy Sports (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASO#NASDAQ">ASO</a>) with a Outperform and maintains $60 price target.

Telsey Advisory Group Maintains Outperform on Academy Sports, Maintains $60 Price Target

B of A Securities analyst Sara Senatore maintains Darden Restaurants (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DRI#NYSE">DRI</a>) with a Buy and raises the price target from $230 to $238.

B of A Securities Maintains Buy on Darden Restaurants, Raises Price Target to $238

Chardan Capital analyst Daniil Gataulin maintains Cognition Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGTX#NASDAQ">CGTX</a>) with a Buy and lowers the price target from $11 to $8.

CGTX

Chardan Capital Maintains Buy on Cognition Therapeutics, Lowers Price Target to $8

ROLR

High Roller Reports Q4 EPS Of $(0.29) Compared With $(0.25) YoY; Revenues Totaled $8.1M Compared With $7.2M YoY

B of A Securities analyst Tazeen Ahmad maintains Alnylam Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALNY#NASDAQ">ALNY</a>) with a Buy and raises the price target from $302 to $325.

ALNY

B of A Securities Maintains Buy on Alnylam Pharmaceuticals, Raises Price Target to $325

President Donald Trump has invoked the Defense Production Act (DPA) to accelerate the development of the <a target="_blank" href="https://www.benzinga.com/markets/commodities" rel="noreferrer noopener">domestic mineral industry</a>, aiming to reduce the reliance on imports and bolster supply chains.
By signing an executive order on Thursday, Trump used the DPA, originally conceived by President Harry Truman, to mobilize industrial resources for national security. The act allows the government to provide financing, issue loans, and invest in projects that strengthen domestic mineral production and processing capabilities.
"The United States was once the world's largest producer of lucrative minerals, but overbearing federal regulation has eroded our nation's mineral production," Trump <a target="_blank" href="https://www.whitehouse.gov/presidential-actions/2025/03/immediate-measures-to-increase-american-mineral-production/" rel="noreferrer noopener">stated</a> in the executive order, clarifying the need to boost mining and refining operations as a national security measure.
His action calls for an expedited permitting process for domestic mining projects, which are <a target="_blank" href="https://www.benzinga.com/news/24/07/39870803/us-mine-development-delays-among-worlds-longest-second-only-to-zambia" rel="noreferrer noopener">among the slowest</a> in the world, along with increased federal land access for mineral extraction.
The U.S. International Development Finance Corporation, in coordination with the Department of Defense, is also set to provide financial support for new mining ventures.
The White House has long voiced concerns over the domestic dependence on foreign sources for critical minerals. President Joe Biden has <a target="_blank" href="https://www.benzinga.com/government/22/06/27559638/biden-set-to-announce-executive-order-to-revive-stalled-solar-projects-in-u-s-report" rel="noreferrer noopener">previously invoked DPA</a> to expand the production of battery metals, including lithium, nickel, and cobalt, recognizing the importance of these metals for many modern technologies – including batteries, semiconductors, defense systems, and green energy, and allowing companies to access $750 million in federal funding.
Trump's action goes further by expanding the list of priority minerals to include uranium, potash, and possibly coal – which he plans to leverage to bring down the cost of energy, <a target="_blank" href="https://in.benzinga.com/25/03/44375055/trump-turns-to-beautiful-clean-coal-to-address-domestic-energy-demand" rel="noreferrer noopener">helping industrial competitiveness</a>.
While China's 70% control over rare earth processing has been a concern, recent export restrictions of elements such as gallium and germanium have worsened the situation, raising concerns over supply shortages for U.S. manufacturers.
Besides boosting domestic production, Trump is also pursuing international agreements, including a <a target="_blank" href="http://e" rel="noreferrer noopener">potential deal with DR Congo</a> (the leading exporter of cobalt) and Ukraine.
"One of the things we are doing is signing a deal very shortly with respect to rare earths with Ukraine… They have tremendous value in rare earths, and we appreciate that," Trump said <a target="_blank" href="https://www.aljazeera.com/economy/2025/3/21/trump-orders-increased-minerals-production-says-ukraine-deal-coming-soon" rel="noreferrer noopener">per</a> Al Jazeera.
After weeks of negotiation, the deal regarding Ukraine's minerals fell through during Ukrainian President Volodymyr Zelensky's last visit to the White House, when tensions between the two leaders <a target="_blank" href="https://in.benzinga.com/news/global/25/02/44057033/this-is-something-that-president-trump-does-over-and-over-again-geopolitical-strategist-says-about-failed-rare-minerals-deal-with-ukraine-president-zelenskyy" rel="noreferrer noopener">derailed negotiations</a>. Since then, both sides have expressed willingness to move forward, signaling that the deal might happen soon.
Price Watch: Sprott Critical Materials (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SETM#NASDAQ">SETM</a>) is up 3.89% year-to-date.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/03/44414283/copper-surges-as-arbitrage-opportunity-drives-us-imports" target="_blank" rel="noreferrer noopener">Copper Surges As Arbitrage Opportunity Drives US Imports</a></li>
</ul>
Image via Shutterstock

Government

Financing

Commodities

Legal

Markets

FDTS

ISVL

NIKL

SETM

YDEC

Trump Invokes An Act From 1950s To Boost Domestic Mineral Industry

HC Wainwright &amp; Co. analyst Emily Bodnar reiterates Context Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNTX#NASDAQ">CNTX</a>) with a Buy and maintains $5 price target.

Reiteration

CNTX

HC Wainwright & Co. Reiterates Buy on Context Therapeutics, Maintains $5 Price Target

Microchip Technology Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MCHP#NASDAQ">MCHP</a>) shares are trading relatively flat on Friday<a target="_blank" href="https://www.benzinga.com/premarket" rel="noreferrer noopener"> in the premarket session.</a>
The firm has priced its <a target="_blank" href="https://www.benzinga.com/25/03/44413101/whats-going-on-microchip-technology-shares-premarket-on-thursday" rel="noreferrer noopener">previously </a>announced underwritten public offering of $1.35 billion of depositary shares, each representing a 1/20th interest in a share of newly issued 7.50% Series A Mandatory <a target="_blank" href="https://www.benzinga.com/pressreleases/25/03/g44429688/microchip-technology-announces-pricing-of-offering-of-depositary-shares-representing-interests-in-" rel="noreferrer noopener">Convertible Preferred Stock.</a>
The offering is priced at $50.00 per depositary share, with the offering expected to close on March 25.
Microchip has granted underwriters a 13-day option to purchase an additional $135 million of depositary shares to cover over-allotments.
The net proceeds, estimated at approximately $1.32 billion, will primarily be used to repay existing debt, including notes under the company's commercial paper program.
Also Read: <a target="_blank" href="https://www.benzinga.com/analyst-ratings/analyst-color/25/03/44423259/holley-may-bear-the-brunt-of-ongoing-macroeconomic-challenges-analyst-highlights-softer-top-line-outlook" rel="noreferrer noopener">Holley May Bear The Brunt Of Ongoing Macroeconomic Challenges, Analyst Highlights Softer Top-line Outlook</a>
Additionally, around $50.1 million will go towards paying for capped call transactions. If the over-allotment option is exercised, some of the proceeds will be directed toward additional capped call transactions.
In other news, Microchip recently introduced a new offering for the <a target="_blank" href="https://www.benzinga.com//node/44353847" rel="noreferrer noopener">electric two-wheeler (E2W) industry.</a>
The company's E2W ecosystem provides scalable solutions to optimize performance in electric scooters and bikes.
Key offerings include advanced battery management systems (BMS) that enhance power efficiency, extend battery life, and improve safety, helping manufacturers develop reliable, feature-rich products with quicker market entry.
As of December 31, cash and short-term&nbsp;<a target="_blank" href="https://www.benzinga.com/pressreleases/25/02/g43545040/microchip-technology-announces-financial-results-for-third-quarter-of-fiscal-year-2025" rel="noreferrer noopener">investments of the firm stood at $586 million</a>.
According to&nbsp;<a target="_blank" href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw" rel="noreferrer noopener">Benzinga Pro</a>, MCHP stock has lost over 42% in the past year. Investors can gain exposure to the stock via First Trust S&amp;P 500 Diversified Dividend Aristocrats ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KNGZ#NASDAQ">KNGZ</a>).
Price Action: MCHP shares are trading lower by 0.45% to $50.77 in the premarket session on Friday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/movers/25/03/44423418/amentum-faces-growth-slump-as-government-cuts-spending-analyst-expects-merger-to-boost-margins" target="_blank" rel="noreferrer noopener">Amentum Faces Growth Slump As Government Cuts Spending, Analyst Expects Merger To Boost Margins</a></li>
</ul>
Photo via Shutterstock.

Equities

Offerings

Movers

General

KNGZ

MCHP

What's Going On With Microchip Technology Stock Today?

Chardan Capital analyst Keay Nakae maintains Allurion Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALUR#NYSE">ALUR</a>) with a Neutral and announces $2.5 price target.

ALUR

Chardan Capital Maintains Neutral on Allurion Technologies, Announces $2.5 Price Target

B of A Securities analyst Craig Bijou maintains RxSight (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RXST#NASDAQ">RXST</a>) with a Buy and lowers the price target from $60 to $36.

RXST

B of A Securities Maintains Buy on RxSight, Lowers Price Target to $36

SNGX

Soligenix Reported Revenues Of $0.1M For Year Ended December 31, 2024, Compared To $0.8M YoY;  Company's Cash Position Was $7.8M

HC Wainwright &amp; Co. analyst Swayampakula Ramakanth maintains Vor Biopharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VOR#NASDAQ">VOR</a>) with a Buy and lowers the price target from $17.5 to $13.

HC Wainwright & Co. Maintains Buy on Vor Biopharma, Lowers Price Target to $13

23andMe Unveils New Homocysteine (MTHFR-Related) Genetic Report And Accompanying Lab Test

Anteris Reports One-Year Patient Outcomes For DurAVR THV: Says It Demonstrated Favorable Hemodynamic Profile Sustained To One year

AstraZeneca Announced Global Collaboration With Harbour BioMed To Develop Next-Gen Therapeutic Antibodies, Including $105M Equity Investment, $175M Upfront, Up To $4.4B In Milestones, And Acquisition Of 9.15% Newly Issued Shares Of Harbour BioMed

Comments

Japan Airlines Co

Japan Airlines Co (JPNRF) オプション

No option chain data available. Please try again later

ニュース

パートナーシップ

ベンジンガ・グローバル